Management of Myeloma Patients During the COVID-19 Pandemic
Recommendations from the International Myeloma Society
Recommendations from the International Myeloma Society
The AMaRC 18-02 study (IRIL) is now available at Flinders Medical Centre
The AMaRC 18-02 study (IRIL) is now available at Concord Hospital
COVID-19 (also known as the Coronavirus disease 2019) is a respiratory illness caused by a novel (or new) coronavirus that was first identified in an outbreak in Wuhan, China in December 2019.
The theme for this year's Myeloma Action Month by the International Myeloma Foundation (IMF) is resilience
Featuring Dr Michael Low, Dr George Grigoriadis, Mr John Doutch and Ms Cathy Rose
The AMaRC 18-02 study (IRIL) is now available at Royal Hobart Hospital
The AMaRC 18-02 study (IRIL) is now available at Calvary Mater Newcastle
Multiple Myeloma epidemiology and survival, a unique malignancy